Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Neuroblastoma 5Central Nervous System Neoplasms 5Astrocytoma 4Myeloproliferative Disorders 3Multiple Myeloma 3Medulloblastoma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Hodgkin Disease 3Breast Neoplasms 3Wilms Tumor 2Testicular Neoplasms 2Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Oligodendroglioma 2Neoplasms 2Mycosis Fungoides 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Thrombopoietin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Carboplatin 2sodium thiosulfate 1romiplostim 1pegfilgrastim 1etoposide phosphate 1Temozolomide 1Rituximab 1Radiotherapy 1Ifosfamide 1Cytarabine 1Cyclophosphamide 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Amplified Fragment Length Polymorphism Analysis × CNS × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡